TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
NBAB, Nordic BioAnalysis AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
6,737
|
5,602
|
3,097 |
Financial expenses |
28
|
4
|
0 |
Earnings before taxes |
-214
|
-631
|
42 |
EBITDA |
-104
|
-688
|
76 |
Total assets |
3,719
|
3,526
|
3,961 |
Current assets |
3,216
|
3,268
|
3,766 |
Current liabilities |
1,981
|
1,703
|
1,291 |
Equity capital |
1,618
|
1,823
|
2,670 |
- share capital |
83
|
82
|
89 |
Employees (average) |
8
|
6
|
4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
43.5%
|
51.7%
|
67.4% |
Turnover per employee |
842
|
934
|
774 |
Profit as a percentage of turnover |
-3.2%
|
-11.3%
|
1.4% |
Return on assets (ROA) |
-5.0%
|
-17.8%
|
1.1% |
Current ratio |
162.3%
|
191.9%
|
291.7% |
Return on equity (ROE) |
-13.2%
|
-34.6%
|
1.6% |
Change turnover |
1,106
|
2,756
|
-2,354 |
Change turnover % |
20%
|
97%
|
-43% |
Chg. No. of employees |
2
![]() |
2
|
0 |
Chg. No. of employees % |
33%
|
50%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.